Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Tuberous Sclerosis × Simvastatin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 7 Polycystic Ovary Syndrome 5 Multiple Myeloma 5 Prostatic Neoplasms 4 Neoplasm Metastasis 3 Colorectal Neoplasms 3 Stomach Neoplasms 2 Small Cell Lung Carcinoma 2 Pancreatic Neoplasms 2 Carcinoma, Intraductal, Noninfiltrating 2 Breast Carcinoma In Situ 2 Wilms Tumor 1 Venous Thromboembolism 1 Urinary Bladder Neoplasms 1 Tuberous Sclerosis 1 Triple Negative Breast Neoplasms 1 Thrombosis 1 Smoldering Multiple Myeloma 1 Sarcoma, Ewing 1 Sarcoma, Clear Cell 1 Sarcoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Retinoblastoma 1 Rectal Neoplasms 1 Perioperative Inflammatory Response 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neurotoxicity Syndromes 1 Neuroblastoma 1

Interventions

Sirolimus 12 Everolimus 10 Activator Appliances 3 Vigabatrin 2 carbon-11 acetate 1 Urination 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Simvastatin 1 Sertraline 1 Selective Serotonin Reuptake Inhibitors 1 Propranolol 1 Phlebotomy 1 Genetic Testing 1 Fluid Therapy 1 Doxycycline 1 Curcumin 1 Calcitriol 1 Aspirin 1 Anticonvulsants 1 Actigraphy 1 Acceptance and Commitment Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02061397 2020-08-25

SOS

University of Pennsylvania

Phase 1/2 Completed

10 enrolled 6 charts

Tuberous Sclerosis, Lymphangioleiomyomatosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡